{"entity":{"id":"nct07038343","kind":"trial","name":"AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)","aka":["AVENTINE-1"],"tldr":"A phase 1/2 trial of AVZO-1418 in biliary tract cancer, bladder & urothelial cancer and nasopharyngeal carcinoma, run by Avenzo Therapeutics, Inc., now recruiting.","summary":"AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) is a phase 1/2 interventional study registered as NCT07038343 by Avenzo Therapeutics, Inc., with 480 participants planned, started 2025-06-04 and due to reach its primary completion in 2030-06. Interventions recorded: AVZO-1418, Combination Agent 1 and Combination Agent 2.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07038343","url":"https://clinicaltrials.gov/study/NCT07038343"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["cholangiocarcinoma","urothelial","nasopharyngeal"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["avenzo"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07038343","phase":"1/2","setting":"A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors","sponsor":"Avenzo Therapeutics, Inc.","participation":[{"nct":"NCT07038343","source":"https://clinicaltrials.gov/study/NCT07038343","fetchedAt":"2026-10-07T16:55:22.250Z","studySha256":"183a3064b0ca20d6a4b9eee89a3c6a1b1255d6c1556b9f4cc3dd91154bfd7741","overallStatus":"RECRUITING","lastUpdatePosted":"2026-09-04","leadSponsor":"Avenzo Therapeutics, Inc.","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"75 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":480,"enrolmentType":"ESTIMATED","siteCount":19,"recruitingSiteCount":19,"countries":["United States"]}],"started":"2025-06-04","startedType":"actual","enrolled":480,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07038343/","neighbours":{"cancer":[{"id":"cholangiocarcinoma","kind":"cancer","name":"Biliary tract cancer (cholangiocarcinoma)","route":"/cancers/cholangiocarcinoma/"},{"id":"urothelial","kind":"cancer","name":"Bladder & urothelial cancer","route":"/cancers/urothelial/"},{"id":"nasopharyngeal","kind":"cancer","name":"Nasopharyngeal carcinoma","route":"/cancers/nasopharyngeal/"}],"company":[{"id":"avenzo","kind":"company","name":"Avenzo Therapeutics","route":"/companies/avenzo/"}]}}